{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["2eef2e91-fac0-4e69-abf6-4e10b69643c9", "4TY", 401104934, "J P FORD STRATEGIES, LLC", 202958, "ALLERGAN USA, INC.", 2018, "fourth_quarter", "2018-12-03T09:01:15.857000-05:00", 20000.0, 0, 0, 1, "{\"url\": \"https://lda.senate.gov/api/v1/filings/2eef2e91-fac0-4e69-abf6-4e10b69643c9/\", \"filing_uuid\": \"2eef2e91-fac0-4e69-abf6-4e10b69643c9\", \"filing_type\": \"4TY\", \"filing_type_display\": \"4th Quarter - Termination (No Activity)\", \"filing_year\": 2018, \"filing_period\": \"fourth_quarter\", \"filing_period_display\": \"4th Quarter (Oct 1 - Dec 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/2eef2e91-fac0-4e69-abf6-4e10b69643c9/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"20000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"John P. Ford\", \"dt_posted\": \"2018-12-03T09:01:15.857000-05:00\", \"termination_date\": \"2018-10-01\", \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1836 Paradise View Court\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Lusby\", \"registrant_state\": \"MD\", \"registrant_zip\": \"20657\", \"registrant\": {\"id\": 401104934, \"url\": \"https://lda.senate.gov/api/v1/registrants/401104934/\", \"house_registrant_id\": null, \"name\": \"J P FORD STRATEGIES, LLC\", \"description\": \"Government relations consulting\", \"address_1\": \"1836 Paradise View Court\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Lusby\", \"state\": \"MD\", \"state_display\": \"Maryland\", \"zip\": \"20657\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"JOHN P. FORD\", \"contact_telephone\": \"+1 443-624-4068\", \"dt_updated\": \"2022-04-06T16:06:29.374930-04:00\"}, \"client\": {\"id\": 202958, \"url\": \"https://lda.senate.gov/api/v1/clients/202958/\", \"client_id\": 12, \"name\": \"ALLERGAN USA, INC.\", \"general_description\": \"Pharmaceutical development and manufacturing\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"NJ\", \"ppb_state_display\": \"New Jersey\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2018-05-25\"}, \"lobbying_activities\": [], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["2eef2e91-fac0-4e69-abf6-4e10b69643c9"], "units": {}, "query_ms": 23.063526023179293, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}